This BMJ paper demonstrates the success of the HPV bivalent vaccine in reducing rates of high and low grade cervical intraepithelial neoplasia (CIN 1,2,3) including the herd immunity effect on women who were unvaccinated.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.